Justin Keywood
Stock Analyst at Stifel Nicolaus
(2.88)
# 2,760
Out of 5,000 analysts
929
Total ratings
52.6%
Success rate
1.1%
Average return
Main Sectors:
Stocks Rated by Justin Keywood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: CPH Cipher Pharmaceuticals Inc. | Reiterated: Buy | $20.00 | $14.27 | +40.15% | 41 | Sep 23, 2026 | |
| TSX: WELL WELL Health Technologies Corp. | Reiterated: Buy | $8.50 | $4.31 | +97.22% | 158 | Sep 23, 2026 | |
| TSX: DHT.UN DRI Healthcare Trust | Reiterated: Buy | $26.00 | $18.13 | +43.41% | 47 | Sep 22, 2026 | |
| TSX: APTX Apotex Health Corp. | Reiterated: Buy | $42.00 | $33.65 | +24.81% | 4 | Sep 21, 2026 | |
| TSXV: NPTH NeuPath Health Inc. | Reiterated: Buy | $0.58 → $0.68 | $0.57 | +19.30% | 10 | Sep 16, 2026 | |
| TSX: ATS ATS Corporation | Reiterated: Buy | $44.00 | $27.09 | +62.42% | 136 | Sep 15, 2026 | |
| TSX: SIS Savaria Corporation | Reiterated: Buy | $35.00 | $29.41 | +19.01% | 65 | Sep 15, 2026 | |
| TSX: CHLT Custom Health Holdings Inc. | Reiterated: Buy | $12.00 | $7.80 | +53.85% | 5 | Sep 11, 2026 | |
| TSX: HLS HLS Therapeutics Inc. | Reiterated: Hold | $4.45 | $3.95 | +12.66% | 103 | Aug 14, 2026 | |
| TSX: AIDX Healwell AI Inc. | Reiterated: Buy | $2.50 → $2.25 | $0.78 | +188.46% | 22 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.45 → $11.00 | $10.09 | +9.02% | 54 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $45.00 → $45.75 | $45.43 | +0.70% | 51 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11.00 | $7.61 | +44.55% | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6.07 | $229.87 | -97.36% | 2 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.50 | $3.16 | +42.41% | 42 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50.00 → $52.00 | $41.38 | +25.66% | 60 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.96 | +206.12% | 14 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.78 | $0.4266 | +316.37% | 1 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1.50 | $0.55 | +172.73% | 4 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6.00 → $3.45 | $5.07 | n/a | 47 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.25 | n/a | 12 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.53 | n/a | 5 | Apr 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 3 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.19 | n/a | 5 | May 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.16 | n/a | 5 | May 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $68.81 | n/a | 17 | May 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $36.60 | n/a | 6 | May 17, 2019 |
Cipher Pharmaceuticals Inc.
Sep 23, 2026
Reiterated: Buy
Price Target: $20.00
Current: $14.27
Upside: +40.15%
WELL Health Technologies Corp.
Sep 23, 2026
Reiterated: Buy
Price Target: $8.50
Current: $4.31
Upside: +97.22%
DRI Healthcare Trust
Sep 22, 2026
Reiterated: Buy
Price Target: $26.00
Current: $18.13
Upside: +43.41%
Apotex Health Corp.
Sep 21, 2026
Reiterated: Buy
Price Target: $42.00
Current: $33.65
Upside: +24.81%
NeuPath Health Inc.
Sep 16, 2026
Reiterated: Buy
Price Target: $0.58 → $0.68
Current: $0.57
Upside: +19.30%
ATS Corporation
Sep 15, 2026
Reiterated: Buy
Price Target: $44.00
Current: $27.09
Upside: +62.42%
Savaria Corporation
Sep 15, 2026
Reiterated: Buy
Price Target: $35.00
Current: $29.41
Upside: +19.01%
Custom Health Holdings Inc.
Sep 11, 2026
Reiterated: Buy
Price Target: $12.00
Current: $7.80
Upside: +53.85%
HLS Therapeutics Inc.
Aug 14, 2026
Reiterated: Hold
Price Target: $4.45
Current: $3.95
Upside: +12.66%
Healwell AI Inc.
Aug 10, 2026
Reiterated: Buy
Price Target: $2.50 → $2.25
Current: $0.78
Upside: +188.46%
Aug 7, 2026
Reiterated: Buy
Price Target: $7.45 → $11.00
Current: $10.09
Upside: +9.02%
Aug 7, 2026
Downgraded: Hold
Price Target: $45.00 → $45.75
Current: $45.43
Upside: +0.70%
Aug 7, 2026
Reiterated: Buy
Price Target: $11.00
Current: $7.61
Upside: +44.55%
Aug 5, 2026
Reiterated: Buy
Price Target: $6.07
Current: $229.87
Upside: -97.36%
Jul 31, 2026
Reiterated: Buy
Price Target: $4.50
Current: $3.16
Upside: +42.41%
Jul 31, 2026
Reiterated: Buy
Price Target: $50.00 → $52.00
Current: $41.38
Upside: +25.66%
May 21, 2026
Reiterated: Buy
Price Target: $6
Current: $1.96
Upside: +206.12%
Mar 20, 2026
Reiterated: Buy
Price Target: $1.78
Current: $0.4266
Upside: +316.37%
Dec 12, 2025
Initiated Coverage: Buy
Price Target: $1.50
Current: $0.55
Upside: +172.73%
Feb 6, 2025
Downgraded: Hold
Price Target: $6.00 → $3.45
Current: $5.07
Upside: n/a
Apr 28, 2023
Rated: Hold
Price Target: n/a
Current: $0.25
Upside: n/a
Apr 3, 2020
Rated: Hold
Price Target: n/a
Current: $1.53
Upside: n/a
Dec 6, 2019
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
May 17, 2019
Rated: Hold
Price Target: n/a
Current: $4.19
Upside: n/a
May 17, 2019
Rated: Hold
Price Target: n/a
Current: $0.16
Upside: n/a
May 17, 2019
Rated: Hold
Price Target: n/a
Current: $68.81
Upside: n/a
May 17, 2019
Rated: Hold
Price Target: n/a
Current: $36.60
Upside: n/a